Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G TopicsPerioperative care — gynaecological surgery

O&G · Perioperative care — gynaecological surgery

Perioperative medication management

Also known as Perioperative drug management · Bridging anticoagulation · Perioperative warfarin · Perioperative DOAC · Perioperative diabetes management · Stress-dose steroids · Perioperative ACEi/ARB · Pre-admission medication review

FRANZCOG reference on perioperative medication management anchored on fetched trial and guideline abstracts: ACCP 2022 against heparin bridging in atrial fibrillation, BRIDGE (no-bridge noninferior for arterial thromboembolism with less major bleeding), PAUSE standardised DOAC interruption without bridging, POISE-1 and POISE-2 harm signals, ENOXACAN-II four-week enoxaparin after abdominal or pelvic cancer surgery, Marik 2008 versus Woodcock 2020 on glucocorticoid cover, Hollmann ACEi/ARB withholding on the morning of surgery, and SGLT2 hold as a guideline interval under challenge. ANZ-first, globally tagged.

high22 referencesUpdated 3 Sept 202614 min readSource-verified · Sept 2026

Checked against its sources on 3 Sept 2026

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCOGMRCOGABOGFRCSCMRCPI

Red flags

  • Active major bleeding on a DOAC — idarucizumab 5 g IV for dabigatran; andexanet alfa (bolus then 2-hour infusion) for factor Xa inhibitors where licensed
  • Do not extrapolate BRIDGE (atrial fibrillation, no routine heparin bridge) to mechanical heart valves — that trial did not answer valve bridging
  • Primary adrenal insufficiency or physiologic replacement steroids — Woodcock 2020: stress-dose hydrocortisone is mandatory and is in addition to usual treatment
  • SGLT2 inhibitor through a prolonged fast, especially in a patient on insulin — euglycaemic DKA risk; international guidelines recommend a 3-to-4-day hold
  • Starting a new beta-blocker 2 to 4 hours before non-cardiac surgery — POISE-1 increased death and stroke
  • Unexplained postoperative hypotension in a steroid-dependent patient — treat as possible adrenal crisis; delays may prove fatal
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCOGMRCOGABOGFRCSCMRCPI

Red flags

  • Active major bleeding on a DOAC — idarucizumab 5 g IV for dabigatran; andexanet alfa (bolus then 2-hour infusion) for factor Xa inhibitors where licensed
  • Do not extrapolate BRIDGE (atrial fibrillation, no routine heparin bridge) to mechanical heart valves — that trial did not answer valve bridging
  • Primary adrenal insufficiency or physiologic replacement steroids — Woodcock 2020: stress-dose hydrocortisone is mandatory and is in addition to usual treatment
  • SGLT2 inhibitor through a prolonged fast, especially in a patient on insulin — euglycaemic DKA risk; international guidelines recommend a 3-to-4-day hold
  • Starting a new beta-blocker 2 to 4 hours before non-cardiac surgery — POISE-1 increased death and stroke
  • Unexplained postoperative hypotension in a steroid-dependent patient — treat as possible adrenal crisis; delays may prove fatal
One-line fellowship answer

Perioperative medication management is a risk-stratification exercise. Classify every chronic drug into continue, withhold, bridge or reverse. For atrial fibrillation, ACCP 2022 strongly recommends against heparin bridging and BRIDGE showed forgoing bridging was noninferior for arterial thromboembolism with less major bleeding. For DOACs, PAUSE omitted one day before low-bleeding-risk procedures and two days before high-bleeding-risk procedures, without heparin bridging. Extended four-week LMWH after abdominal or pelvic cancer surgery is the ACCP/ENOXACAN-II rule. Do not start a new beta-blocker on the day of surgery (POISE-1).[1][2][3][8][11]

It is the Wednesday before Mrs Lim's cytoreductive surgery. She takes apixaban for atrial fibrillation, metformin and glargine for type 2 diabetes, ramipril for hypertension, and prednisolone 10 mg daily for polymyalgia rheumatica. The pre-admission clinic is where this list becomes a written day-of-surgery prescription. This topic is the script for that conversation — restricted to numbers that sit in fetched abstracts.[1][16]

Overview and definition

Perioperative medication management turns a chronic drug list into a safe day-of-surgery plan. It has three complementary parts:[1][4]

  • Stratify the drug — continue unchanged, withhold on the day, withhold for one or more days, or reverse in haemorrhage.
  • Stratify the patient — thrombotic indication (atrial fibrillation, mechanical valve, recent VTE, active cancer) versus bleeding risk of the procedure.
  • Stratify the surgery — magnitude, anaesthetic technique (including neuraxial), and urgency (elective versus emergent).[3][4]
The four-trial summary at the door
"BRIDGE / PAUSE / POISE / ENOX" — BRIDGE ended routine heparin bridging for atrial fibrillation; PAUSE standardised DOAC interruption without bridging; POISE-1 showed harm from starting metoprolol immediately before non-cardiac surgery; ENOXACAN-II supported four weeks of enoxaparin after abdominal or pelvic cancer surgery.[2][3][8][10]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References22ShowHide
  1. [1]Douketis JD, Spyropoulos AC, Murad MH, et al. Executive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline. Chest, 2022.PMID 35964703
  2. [2]Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, et al. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med, 2015.PMID 26095867
  3. [3]Douketis JD, Spyropoulos AC, Duncan J, Carrier M, et al. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med, 2019.PMID 31380891
  4. [4]Douketis JD, Spyropoulos AC Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review. JAMA, 2024.PMID 39133476
  5. [5]Pollack CV Jr, Reilly PA, Eikelboom J, et al. Idarucizumab for Dabigatran Reversal. N Engl J Med, 2015.PMID 26095746
  6. [6]Connolly SJ, Crowther M, Eikelboom JW, et al. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. N Engl J Med, 2019.PMID 30730782
  7. [7]Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med, 2014.PMID 24679062
  8. [8]Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet, 2008.PMID 18479744
  9. [9]Devereaux PJ, Sessler DI, Leslie K, Kurz A, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med, 2014.PMID 24679061
  10. [10]Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med, 2002.PMID 11919306
  11. [11]Gould MK, Garcia DA, Wren SM, Karanicolas PJ, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012.PMID 22315263
  12. [12]American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology Prevention of Venous Thromboembolism in Gynecologic Surgery: ACOG Practice Bulletin, Number 232. Obstet Gynecol, 2021.PMID 34259490
  13. [13]Hollmann C, Fernandes NL, Biccard BM A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery. Anesth Analg, 2018.PMID 29381513
  14. [14]Marik PE, Varon J Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg, 2008.PMID 19075176
  15. [15]Woodcock T, Barker P, Daniel S, Fletcher S, et al. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia, 2020.PMID 32017012
  16. [16]Barker P, Creasey PE, Dhatariya K, et al. Peri-operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia, 2015.PMID 26417892
  17. [17]Kotagal M, Symons RG, Hirsch IB, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg, 2015.PMID 25133932
  18. [18]Haziri F, Durak K, Glarner N, Ergin E, et al. Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: secondary analysis of two prospective observational cohort studies. Br J Anaesth, 2026.PMID 42270529
  19. [19]Lozada GA, Chen RB, Davoud S, Lee GS Perioperative Management of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter 2 Inhibitors. Anesthesiol Clin, 2026.PMID 42069389
  20. [20]American Society of Anesthesiologists Committee on Standards and Practice Parameters Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration. Anesthesiology, 2017.PMID 28045707
  21. [21]Nelson G, Bakkum-Gamez J, Kalogera E, et al. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer, 2019.PMID 30877144
  22. [22]Duggan EW, Klopman MA, Berry AJ, Umpierrez G The Emory University Perioperative Algorithm for the Management of Hyperglycemia and Diabetes in Non-cardiac Surgery Patients. Curr Diab Rep, 2016.PMID 26971119

Test yourself

Practise what you just read

  • 10 MCQs
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPerineal wound complications and breakdownPostpartum care — perineal health and wound careNextPre-operative assessment and optimisationPerioperative care — gynaecological surgery